Understanding the Medication Access Landscape
The 2025 Medication Access Report: From Barriers to Bridges, released by CoverMyMeds, underscores a crucial need for collaboration and improved interoperability within the healthcare sector to enhance patient outcomes.
Key Findings of the Report
Among the alarming statistics revealed, a significant 65% of patients have faced delays in obtaining their medications. Additionally, 54% express serious concerns regarding the costs involved with their prescriptions. As this report highlights, medication affordability ranks as the second most crucial consideration for patients after the effectiveness of the drugs.
The Patient Experience
A shocking insight from the report indicates that one in five patients have altered their prescriptions due to cost concerns, while almost as many left pharmacies without their medication after discovering unexpectedly high prices. This presents a troubling picture of the existing barriers faced by patients in the healthcare system.
Fragmentation in the Healthcare System
The ongoing challenges of medication access and affordability are largely attributed to persistent fragmentation among pharmaceutical companies, prescribers, pharmacies, and payers. Over the years, this fragmentation has exacerbated, particularly due to rapidly changing industry dynamics, the emergence of specialty medications, shifts in public policies, and the integration of artificial intelligence (AI). These changes, coupled with the multifaceted needs of patients, have created significant barriers that require urgent attention.
A Call for Action
Kevin Kettler, the President of CoverMyMeds, emphasizes the need for a collective effort to address these challenges. He states, “Patients are ultimately the ones shouldering the burden of the barriers that exist between various healthcare organizations playing a part in their care.” The report serves as an urgent call to action for industry stakeholders to innovate, collaborate, and prioritize patient-centered strategies that transform these barriers into bridges.
Strategies for Improvement
CoverMyMeds has devoted over a decade to deriving insights from industry statistics, market research, patient interviews, and survey data to understand critical barriers hindering patients' access to medications. This annual report aims to empower healthcare professionals with actionable strategies to counter such challenges in the following key areas:
1. Reimagining the Patient Journey
The complexities of the U.S. healthcare system necessitate a rethinking of how the patient journey is defined and supported. The report introduces an emerging approach termed 'Dimensionalization,' which considers the comprehensive spectrum of a patient's experience. This includes not only their medical conditions but also social determinants of health and interactions with various healthcare stakeholders.
2. Enhancing Data Sharing & Interoperability
Effective collaboration and data sharing are essential to tackle the intricate challenges faced in today’s healthcare landscape. However, many of the necessary tools for achieving these goals remain underutilized. The implementation of centralized data systems can facilitate synchronization among stakeholders—from pharmacies to healthcare providers—significantly minimizing discrepancies and ensuring treatment aligns with patient needs.
3. Addressing Drug Pricing Dynamics
Challenges concerning medication affordability are one of the pivotal gaps hindering patients from obtaining necessary medicines. Optimizing workflows and employing integrated care models can help stakeholders improve access to medications. The introduction of responsible AI solutions, educating patients about policies, and promoting at-home administration are just a few strategies detailed in the report.
4. Fostering Patient Engagement and Support Programs
Patient Support Programs (PSPs) play a crucial role in fostering communication and bridging medication access gaps throughout the patient journey. It’s evident that patients prefer digital communication channels with their healthcare providers and expect a seamless, user-friendly experience when engaging with healthcare platforms.
The Research Basis of the Report
Insights in the 2025 Medication Access Report derive from six phases of proprietary research conducted by CoverMyMeds over the past year, which involved 180 qualitative interviews and analysis of 777 quantitative responses from various stakeholders in the healthcare sector.
About CoverMyMeds
CoverMyMeds, now part of McKesson Corporation, is dedicated to enhancing medication access for individuals, helping them obtain the necessary prescriptions to lead healthier lives. By fostering innovation and collaboration, CoverMyMeds aims to seamlessly connect healthcare networks, thereby improving medication access, expediting therapy initiation, and reducing prescription abandonment rates. The company’s extensive network encompasses over 350 electronic health record (EHR) systems, more than 50,000 pharmacies, and almost one million providers across various health plans and pharmacy benefit managers (PBMs).
Frequently Asked Questions
What is the focus of the 2025 Medication Access Report?
The report emphasizes the need for collaboration within the healthcare industry to overcome barriers related to medication access and affordability.
What are some key findings from the report?
Key findings include that 65% of patients face delays in accessing medications, while 54% express concerns about medication costs.
How can healthcare stakeholders improve the patient experience?
By rethinking patient journeys, enhancing data sharing, and fostering patient engagement through support programs.
What does the term 'Dimensionalization' refer to?
Dimensionalization involves understanding a patient's full experience, including social determinants of health and medical interactions, to personalize treatment pathways.
How can patients benefit from the insights in the report?
The report provides actionable strategies that healthcare professionals can utilize to improve patient access to necessary medications and enhance overall healthcare experiences.
